09/16/2024
3:34 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
09/12/2024
3:56 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel GP Ltd. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:16 AM | Chemomab Therapeutics (Filer)
| Form 424B3 | |
09/08/2024
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
08/21/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
1:36 PM | Chemomab Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
08/09/2024
3:39 PM | Chemomab Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/25/2024
7:09 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
6:05 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
5:03 AM | Chemomab Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/11/2024
6:19 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
03/07/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023
3:35 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
11/09/2023
7:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2023
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
10/30/2023
7:33 AM | Chemomab Therapeutics (Filer)
| Form F-3/A | |
10/16/2023
3:25 PM | Chemomab Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
